BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 27195752)

  • 1. Lung Capillary Stress Failure and Arteriolar Remodelling in Pulmonary Hypertension Associated with Left Heart Disease (Group 2 PH).
    Dayeh NR; Ledoux J; Dupuis J
    Prog Cardiovasc Dis; 2016; 59(1):11-21. PubMed ID: 27195752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung capillary injury and repair in left heart disease: a new target for therapy?
    Azarbar S; Dupuis J
    Clin Sci (Lond); 2014 Jul; 127(2):65-76. PubMed ID: 24678967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and clinical relevance of pulmonary remodelling in pulmonary hypertension due to left heart diseases.
    Dupuis J; Guazzi M
    Can J Cardiol; 2015 Apr; 31(4):416-29. PubMed ID: 25840093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction and lung capillary injury in cardiovascular diseases.
    Guazzi M; Phillips SA; Arena R; Lavie CJ
    Prog Cardiovasc Dis; 2015; 57(5):454-62. PubMed ID: 25446556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular heart failure and pulmonary hypertension.
    Rosenkranz S; Gibbs JS; Wachter R; De Marco T; Vonk-Noordegraaf A; Vachiéry JL
    Eur Heart J; 2016 Mar; 37(12):942-54. PubMed ID: 26508169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical stretching of the pulmonary vein mediates pulmonary hypertension due to left heart disease by regulating SAC/MAPK pathway and the expression of IL-6 and TNF-α.
    Huang W; Liu H; Pan Y; Yang H; Lin J; Zhang H
    J Cardiothorac Surg; 2021 May; 16(1):127. PubMed ID: 33971931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload.
    Lambert M; Mendes-Ferreira P; Ghigna MR; LeRibeuz H; Adão R; Boet A; Capuano V; Rucker-Martin C; Brás-Silva C; Quarck R; Domergue V; Vachiéry JL; Humbert M; Perros F; Montani D; Antigny F
    Cardiovasc Res; 2021 Nov; 117(12):2474-2488. PubMed ID: 33483721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells promote lung vascular remodelling in pulmonary hypertension.
    Hoffmann J; Yin J; Kukucka M; Yin N; Saarikko I; Sterner-Kock A; Fujii H; Leong-Poi H; Kuppe H; Schermuly RT; Kuebler WM
    Eur Respir J; 2011 Jun; 37(6):1400-10. PubMed ID: 21148228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary hypertension – a common condition in left heart disease].
    Lundgren J; Rådegran G
    Lakartidningen; 2017 Dec; 114():. PubMed ID: 29292958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary Hypertension Due to Left Ventricular Cardiomyopathy: Is it the Result or Cause of Disease Progression?
    Adusumalli S; Mazurek JA
    Curr Heart Fail Rep; 2017 Dec; 14(6):507-513. PubMed ID: 29063280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy.
    Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ
    Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
    Omote K; Sorimachi H; Obokata M; Reddy YNV; Verbrugge FH; Omar M; DuBrock HM; Redfield MM; Borlaug BA
    Eur Heart J; 2022 Sep; 43(36):3417-3431. PubMed ID: 35796488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition from post-capillary pulmonary hypertension to combined pre- and post-capillary pulmonary hypertension in swine: a key role for endothelin.
    van Duin RWB; Stam K; Cai Z; Uitterdijk A; Garcia-Alvarez A; Ibanez B; Danser AHJ; Reiss IKM; Duncker DJ; Merkus D
    J Physiol; 2019 Feb; 597(4):1157-1173. PubMed ID: 29799120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.
    Sang P; Kucherenko MM; Yao J; Li Q; Simmons S; Kuebler WM; Knosalla C
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35311828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension associated with left heart disease.
    Adir Y; Amir O
    Semin Respir Crit Care Med; 2013 Oct; 34(5):665-80. PubMed ID: 24037633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical stretching of pulmonary vein stimulates matrix metalloproteinase-9 and transforming growth factor-β1 through stretch-activated channel/MAPK pathways in pulmonary hypertension due to left heart disease model rats.
    Zhang H; Huang W; Liu H; Zheng Y; Liao L
    PLoS One; 2020; 15(9):e0235824. PubMed ID: 32881898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient.
    Ibe T; Wada H; Sakakura K; Ikeda N; Yamada Y; Sugawara Y; Mitsuhashi T; Ako J; Fujita H; Momomura S
    J Cardiol; 2016 Jun; 67(6):555-9. PubMed ID: 26299611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of pulmonary hypertension in left heart disease.
    Schmeisser A; Schroetter H; Braun-Dulleaus RC
    Ther Adv Cardiovasc Dis; 2013 Jun; 7(3):131-51. PubMed ID: 23592742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.